Header
SABPA Newsletter, October 2018

SABPA Events

The 4th Annual SABPA-UCSD Career Development Forum

Inside the Hiring Managers’ Mind
When: Thursday, November 15th, 2017, 5:30 – 8:30pm
Where: Sanford Consortium, Auditorium, 2880 Torrey Pines Scenic Drive, La Jolla, CA 92037
Registration opens in mid-October.
While many postdocs are interested in career opportunities in the biotech and pharmaceutical industry, it remains very challenging to navigate the application process and understand what it actually takes to obtain an industry position.
In the 4th Annual Joint Career Development Forum co-organized by SABPA Education & Career Development (ECD) Committee and UCSD Postdoc Association (PDA), we have invited industry hiring managers who have hired candidates at various career stages from local life science industry to form an interactive panel, sharing with the audience their perspectives of the industry hiring process and discussing the qualifications, experience and many other qualities of the successful candidates.
Tentative Schedule:
5:30 – 6:15 PM           Registration & Networking Dinner
6:15 – 6:30 PM           Welcome by SABPA ECD and UCSD PDA
6:30 – 8:00 PM           Panel Discussion
8:00 – 8:30 PM           Networking

SABPA Reports

7th SABPA/ACS Chemistry Symposium
Thursday, September 6, 2018 marked the 7th SABPA/ACS Chemistry Symposium. The event was held at Lilly Biotechnology Center with more than 130 people attending to hear talks given by Dr. Jinglan Zhou, Research Fellow I, Vertex Pharmaceuticals and Professor John L. Wood, of Baylor University. The symposium was very well received and the audience asked many great questions of both speakers both during and after the symposium. The organizing committee would like to thank ChemBridge and Pfizer, for their generous sponsorship.
In her presentation titled “Discovery of Ivacaftor, a CFTR Potentiator for the Treatment of Cystic Fibrosis”, Dr. Zhou talked about the discovery of a novel CFTR potentiator, quinolinone-3-carboxamide, using HTS in NIH-3T3 cells expressing the F508del-CFTR mutation. She then described the medicinal chemistry work used to evaluate the potency, selectivity, and pharmacokinetic properties which resulted in the identification VX-770 which was approved by the FDA in 2012 for the treatment of CF patients 6 years of age and older carrying the G551D mutation (4-5% cases of cystic fibrosis patients).

Professor John L. Wood‘s talk was titled “Recent Efforts in the Synthesis of Complex Natural Products”. Professor Wood started the lecture by reminding us that synthetic chemistry is not just a means to an end product but a process of successes and failures that lead to far more enlightenment than just the synthesis of a final compound. From there, he led us on the 22-year journey of discovery through multiple students to the final synthesis of Phomoidride D. Dr. Wood’s talk was both entertaining and enlightening, giving the audience insight into many aspects of synthesis including the role of trialkylborane-water complexes in reduction reactions such as deoxygenation of xanthates.

Dr. Jinglan Zhou, Research Fellow I, Vertex Pharmaceuticals
Professor John L. Wood, Baylor University
The attendance listening intently during Dr. Zhou’s presentation.
Dr. Scott Sutton (Co-Chair), Dr. Zhou, Dr. David Wallace
(Co-Chair), Professor Wood, and Dr. Yahu Liu (Co-Chair)

By David Wallace.

Community Events

Upcoming UCSD Extension Events

When: Friday, October 19, 2018

8:00 am – 2:00 pm
Microbiome and Bioinformatics Symposium
UNIVERSITY OF CALIFORNIA SAN DIEGO EXTENSION
Contact: Felicia Murray, unexbio@ucsd.edu
When: Friday, November 9th and 10th
10am-4pm
Technology Licensing Course (MCLE Credit and Certificate of completion provided)
UNIVERSITY OF CALIFORNIA SAN DIEGO EXTENSION
Contact: Julia Dunlap, unexlaw@ucsd.edu

The China Healthcare Summit 2018
The Bridge to Innovation

When:    November 13-14, 2018
Where:   Shanghai, China
Register now:

SABPA Members: Save an Additional 20% on Registration with Discount Code: SABPA2018

BioCentury and BayHelix Present: The 5th China Healthcare Summit in Shanghai November 13-14, 2018. The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting.

Seating is limited, so register today to reserve your seat and “Early-Bird” discount.

8 Reasons to Join Us in Shanghai

> Two days of strategic sessions and keynotes tailored to help busy executives understand emerging opportunities and challenges in China.

> The China Summit report created by Insights Partner, McKinsey & Company. This exclusive analysis documents market trends and identifies business imperatives for biopharma and life sciences companies doing business in China.

> New for 2018: For the 1st time, the China Summit will feature a presenting company track to showcase biotechs from China, Asia and the West, hand-picked by BioCentury and BayHelix.

> New for 2018: A 1×1 meeting system will allow attendees to arrange face-to-face discussions with investors and corporate delegates.

> Learn how biopharma CEOs, heads of research and leading investors are leveraging China’s innovation, policy initiatives and access to capital markets in HK and domestic exchanges to build a globally facing industry.

> Three VIP receptions to network with senior-level executives and investors.

> The annual BayHelix Awards ceremony and lunch to celebrate R&D and commercial achievements in China.

> Multiple networking breaks throughout the event to meet peers across the China innovation ecosystem.

The China Summit agenda has been developed by an Organizing Committee that includes China industry KOLs and BioCentury’s editorial team. Simultaneous translation is provided in all strategic sessions.

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
About SABPA
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.

Think about the purpose of your email: You want readers to respond in a certain way, so make sure to spell it out for them. Use specific calls-to-action such as visit our website, shop the sale now, or sign up for specials.

Call-to-Action Link

SABPA.org, P.O. BOX 927631, San Diego, CA 92192
Sent by member@sabpa.org in collaboration with